Keyphrases
Small Interfering RNA (siRNA)
100%
B-cell Lymphoma 2 (Bcl-2)
100%
5-fluorouracil (5-FU)
100%
Stomach Cancer
100%
Co-delivery
100%
Glucan
100%
Stomach
37%
Mouse Tumor Model
37%
C57BL
25%
Therapeutic Modalities
25%
Therapeutic Efficacy
25%
Early Diagnosis
12%
Therapeutic Outcome
12%
Mucus
12%
Hispanic
12%
Apoptosis
12%
Ki-67
12%
Extended Period
12%
Western Blotting
12%
Gastric Cancer
12%
Potential Therapeutics
12%
Immunohistochemistry
12%
Remission
12%
Histology
12%
Therapeutic Effect
12%
Cancer Mortality
12%
Delivery Approaches
12%
Conventional Treatment
12%
TUNEL
12%
High Inhibition
12%
TUNEL Assay
12%
Improved Efficacy
12%
Oral Delivery
12%
Delivery Vehicle
12%
Local Delivery
12%
Tumor Region
12%
Systemic Delivery
12%
Oral Formulation
12%
Simulated Gastric Fluid
12%
Pharmacology, Toxicology and Pharmaceutical Science
Small Interfering RNA
100%
Stomach Cancer
100%
Fluorouracil
100%
Glucan
100%
Mouse Model
37%
Malignant Neoplasm
37%
Combination Therapy
25%
Mouse
12%
Therapeutic Effect
12%
Western Blot
12%
C57BL 6 Mouse
12%
Side Effect
12%
Remission
12%
Neoplasm
12%